Clinical Trial Results: Antecedent Metabolic Health and Metformin Aging Study [Phase 3]

View source ↗

Summary

Phase 3 trial results on antecedent metabolic health and metformin's impact on aging and insulin sensitivity have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Insulin Resistance

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Oklahoma Medical Research Foundation | Conditions: Aging, Insulin Sensitivity | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02